Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Classement en actions #32247
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Prix de l'action
$4.65
Dernière synchronisation: 2024-07-24
Capitalisation boursière
$10.63M
Changement (1 jour)
6.66%
Changement (1 an)
0.00%
Pays
AU
Échange Medlab Clinical Limited (MDC)

Catégorie

EPS pour Medlab Clinical Limited (MDC)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Medlab Clinical Limited, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Medlab Clinical Limited de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH
- -
KR